Radiofrequency Ablation in Relieving Pain in Patients With Bones Metastases
Completed · Phase 2
Conditions studied: Metastatic Cancer, Pain
In brief
RATIONALE: Radiofrequency ablation uses high-frequency electric current to kill tumor cells and may help to relieve pain caused by bone metastases. PURPOSE: Phase II trial to study the effectiveness of radiofrequency ablation in relieving pain in patients who have bone metastases.
Key facts
- Study ID
- NCT00029029
- Run by
- Mayo Clinic
- Starts
- 2000-10-13
- Expected to finish
- 2002-10-24
- Last updated by the study team
- 2020-08-12
Who can join
Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Northwestern Memorial Hospital — Chicago, Illinois, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — Baltimore, Maryland, United States
- Massachusetts General Hospital Cancer Center — Boston, Massachusetts, United States
- Mayo Clinic Cancer Center — Rochester, Minnesota, United States
- University of Texas - MD Anderson Cancer Center — Houston, Texas, United States
- St. Luke's Medical Center — Milwaukee, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.